$6.73
-0.95 (-12.34%)
At Close: Jun 03, 2026
Corgenix Signs Technology Transfer, Product Development Agreement with Mellitus LLC for Gestational Diabetes Test
09:15am, Monday, 14'th Jul 2014
DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTCBB: CONX), a worldwide developer and marketer of diagnostic test kits, today announced a technology transfer and product development agreement
Corgenix, Research Group Announce NIH Grant to Advance Work on Ebola Rapid Diagnostic Test Kit
09:15am, Thursday, 26'th Jun 2014
DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTC BB: CONX.OB), a worldwide developer and marketer of diagnostic test kits, has been awarded a three-year, $2.9 million National Institutes of
Corgenix Announces CE Mark Notification for TxBCardio™ Assay
09:15am, Thursday, 15'th May 2014
DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTC BB: CONX.OB) announced in collaboration with Randox Laboratories that Randox has been granted CE Mark notification for its TxBCardio™ Assay
Corgenix Reports Third Quarter Fiscal 2014 Financial Results
09:00am, Thursday, 15'th May 2014
DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTCBB: CONX), a worldwide developer and marketer of diagnostic test kits, today filed its third-quarter Form 10-Q and reported its financial resu
Corgenix to Host Conference Call to Discuss Third Quarter Results
09:15am, Thursday, 01'st May 2014
DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTCBB: CONX), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Thursday, May 15, 2014, at 4:00 p.m. EDT
Corgenix, Tulane and Viral Hemorrhagic Fever Consortium Publish Promising Results from Lassa Fever Trial
09:15am, Tuesday, 01'st Apr 2014
DENVER--(BUSINESS WIRE)--A Corgenix Medical (OTCBB:CONX) rapid diagnostic test (RDT) for the dangerous Lassa fever virus has demonstrated the ability to quickly detect the virus, responsible for the d
Corgenix and Research Partners to Expand Ebola Virus Testing Capabilities in Sierra Leone
09:15am, Thursday, 27'th Mar 2014
DENVER--(BUSINESS WIRE)--An outbreak of the deadly Ebola virus in West Africa has prompted Corgenix Medical Corporation (OTCBB:CONX) to extend its existing viral hemorrhagic fever (VHF) rapid test dev
Sign In
Buy CONX